{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:38:06Z","timestamp":1771565886734,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.forsciint.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T23:19:57Z","timestamp":1512775197000},"page":"72-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations"],"prefix":"10.1016","volume":"283","author":[{"given":"Marco","family":"Diestelmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zangl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Herrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Graw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liane D.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2017.12.003_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2009.05.001","article-title":"Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure","volume":"190","author":"Westphal","year":"2009","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0010","unstructured":"H. Koeppe, G. Ludwig, K. Zeile, 1-(3\u2032-4\u2032-Methylenedioxy-phenyl)-2-pyrrolidino-alkanones-(1), US Patent 3478050 A and [Verfahren zur Herstellung von alpha-Aminoketonen mit heterocyclischer Aminogruppe], German Patent DE1545591, 1969."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0015","series-title":"Report on the Risk Assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (3,4 methylenedioxypyrovalerone, MDPV) in the framework of the Council Decision on New Psychoactive Substances","author":"European Monitoring Center for Drugs and Drug Addiction","year":"2014"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainresbull.2016.04.011","article-title":"Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinovalerophenone (alpha-PVP)","volume":"126","author":"Glennon","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/7854_2016_53","article-title":"Neuropharmacology of 3,4-methylenedioxypyrovalerone (MDPV), its metabolites, and related analogs","volume":"32","author":"Baumann","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/acschemneuro.5b00006","article-title":"Stereoselective actions of methylenedioxypyrovalerone (MDPV) to inhibit dopamine and norepinephrine transporters and facilitate intracranial self-stimulation in rats","volume":"6","author":"Kolanos","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of \u2018bath salt\u2019 cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0050","first-page":"185","article-title":"Richtlinie der Gesellschaft f\u00fcr Toxikologische und Forensische Chemie, Anhang B; Anforderung an die Validierung von Analysenmethoden","volume":"76","author":"Peters","year":"2009","journal-title":"Toxichem. Krimtech."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0055","series-title":"UV-Spectra of Toxic Compounds. Database of Photo-diode Array UV Spectra of Illegal and Therapeutic Drugs, Pesticides, Ecotoxic Substances and Other Poisons","author":"Pragst","year":"2001"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1570-0232(03)00124-7","article-title":"Studies on the metabolism and toxicological detection of the Eschscholtzia californica alkaloids californine and protopine in urine using gas chromatography-mass spectrometry","volume":"789","author":"Paul","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0065","series-title":"Mass spectral Library of Drugs, Poisons, Pesticides Pollutants and Their Metabolites","author":"Maurer","year":"2011"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0070","first-page":"186","article-title":"Riding high on cloud 9","volume":"164","author":"Caffery","year":"2012","journal-title":"J. La. State Med. Soc."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13181-014-0446-8","article-title":"Acute Methylenedioxypyrovalerone Toxicity","volume":"11","author":"Froberg","year":"2015","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0080","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","article-title":"Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project","volume":"53","author":"Beck","year":"2015","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.forsciint.2011.03.015","article-title":"New designer drug of abuse: 3,4-methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland","volume":"210","author":"Kriikku","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0090","series-title":"EMCDDA- Europol Joint Report on a New Psychoactive Substance: MDPV (3,4-methylenedioxypyrovalerone)","author":"European Monitoring Center for Drugs and Drug Addiction","year":"2014"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FTD.0b013e318208b693","article-title":"Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry","volume":"33","author":"Ojanpera","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0100","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00216-012-6548-8","article-title":"Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS\/MS analysis","volume":"405","author":"Swortwood","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jat\/bkt025","article-title":"Analysis of MDPV in blood\u2013determination and interpretation","volume":"37","author":"Adamowicz","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0115","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jms.1859","article-title":"Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS","volume":"45","author":"Meyer","year":"2010","journal-title":"J. Mass Spectr."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00414-015-1150-1","article-title":"Driving under the influence of synthetic phenethylamines: a case series","volume":"129","author":"Maas","year":"2015","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0130","first-page":"640","article-title":"Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases","volume":"33","author":"Antonowicz","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12888-016-1002-7","article-title":"Psychosis associated with acute recreational drug toxicity: a European case series","volume":"16","author":"Vallersnes","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1556-4029.12038","article-title":"Acute psychosis induced by bath salts: a case report with clinical and forensic implications","volume":"58","author":"Stoica","year":"2013","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","article-title":"Bath salts mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention","volume":"69","author":"Glennon","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.annemergmed.2012.01.005","article-title":"Hyperthermia and multiorgan failure after abuse of \u201cbath salts\u201d containing 3,4-methylenedioxypyrovalerone","volume":"60","author":"Borek","year":"2012","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0155","series-title":"MDPV, Report, Institute of Psychiatry","author":"Psychonaut WebMapping Research Group","year":"2009"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0160","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.amjmed.2012.02.019","article-title":"Psychoactive \u201cbath salts\u201d intoxication with methylenedioxypyrovalerone","volume":"125","author":"Ross","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0165","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/jcph.742","article-title":"Mephedrone and 3,4-methylenedioxypyrovalerone (MDPV): synthetic cathinones with serious health implications","volume":"56","author":"White","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.forsciint.2014.04.017","article-title":"A 3-year review of new psychoactive substances in casework","volume":"243","author":"Elliott","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5811\/westjem.2011.6.6782","article-title":"Bath salts: the ivory wave of trouble","volume":"13","author":"Olives","year":"2012","journal-title":"West J. Emerg. Med."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2011.10.002","article-title":"3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online","volume":"208","author":"Coppola","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0185","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.genhosppsych.2012.06.005","article-title":"Excited delirium following use of synthetic cathinones (bath salts)","volume":"34","author":"Penders","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.genhosppsych.2011.05.014","article-title":"Hallucinatory delirium following use of MDPV: \u201cBath Salts\u201d","volume":"33","author":"Penders","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0897190012465949","article-title":"Clinical toxicology and management of intoxications with synthetic cathinones (\u201cBath Salts\u201d)","volume":"26","author":"Mas-Morey","year":"2013","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.forsciint.2017.12.003_bib0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12640-016-9640-6","article-title":"Cytotoxic activity of pyrovalerone derivatives, an emerging group of psychostimulant designer cathinones","volume":"30","author":"Wojcieszak","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s13181-012-0232-4","article-title":"Psychosis from a bath salt product containing flephedrone and MDPV with serum urine, and product quantification","volume":"8","author":"Thornton","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2017.12.003_bib0210","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1097\/YCT.0b013e3182887bc2","article-title":"Electroconvulsive therapy improves persistent psychosis after repeated use of methylenedioxypyrovalerone (\u201cbath salts\u201d)","volume":"29","author":"Penders","year":"2013","journal-title":"J. ECT"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073817305108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073817305108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T03:39:32Z","timestamp":1660102772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073817305108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":42,"alternative-id":["S0379073817305108"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2017.12.003","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}